# (-)- Epicatechin Becker Muscular Dystrophy

> **NCT03236662** · PHASE2 · COMPLETED · sponsor: **Craig McDonald, MD** · enrollment: 2 (actual)

## Conditions studied

- Becker Muscular Dystrophy

## Interventions

- **DRUG:** (-)-Epicatechin

## Key facts

- **NCT ID:** NCT03236662
- **Lead sponsor:** Craig McDonald, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2017-11
- **Final completion:** 2017-12
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2021-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236662, "(-)- Epicatechin Becker Muscular Dystrophy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03236662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*